Ming-kang Zhong
12 Middle Urumqi Road
Shanghai, 200040, China
Shanghai, 200040, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Metabolic Remodeling During the Early Phase of Spontaneous Seizure Emergence Highlights Hexosamine Biosynthetic Pathway Dysregulation in Temporal Lobe Epilepsy.
Journal: Journal of neurochemistry
Published: June 02, 2025
Assessment of Rivaroxaban Plasma Concentration Using Chromogenic Anti-Xa Assays and UHPLC-MS/MS in Chinese Patients With Atrial Fibrillation.
Journal: Basic & clinical pharmacology & toxicology
Published: July 30, 2024
Major adverse cardiovascular events associated with testosterone treatment: a pharmacovigilance study of the FAERS database.
Journal: Frontiers in pharmacology
Published: March 08, 2023
Sodium-glucose co-transporter-2 inhibitor (SGLT2i) treatment and risk of osteomyelitis: A pharmacovigilance study of the FAERS database.
Journal: Frontiers in pharmacology
Published: November 29, 2022
Skin cancer signal associated with phosphodiesterase inhibitors: gaining insight through the FDA pharmacovigilance database.
Journal: Expert opinion on drug safety
Published: November 05, 2022
A high-performance liquid chromatography-tandem mass spectrometry method for quantification of perampanel in human plasma: Effect of concomitant anti-seizure medications on perampanel concentration in patients with epilepsy.
Journal: Journal of pharmaceutical and biomedical analysis
Published: September 14, 2022
Population Pharmacokinetic Modeling Combined With Machine Learning Approach Improved Tacrolimus Trough Concentration Prediction in Chinese Adult Liver Transplant Recipients.
Journal: Journal of clinical pharmacology
Published: June 21, 2022
Serious adverse reaction associated with the COVID-19 vaccines of BNT162b2, Ad26.COV2.S, and mRNA-1273: Gaining insight through the VAERS.
Journal: Frontiers in pharmacology
Published: April 16, 2022
Real-World Prescription Patterns For Patients With Young-Onset Parkinson's Disease in China: A Trend Analysis From 2014 to 2019.
Journal: Frontiers in pharmacology
Published: January 19, 2022
Risk for Cardiovascular Adverse Events Associated With Sphingosine-1-Phosphate Receptor Modulators in Patients With Multiple Sclerosis: Insights From a Pooled Analysis of 15 Randomised Controlled Trials.
Journal: Frontiers in immunology
Published: October 15, 2021
Last Updated: 09/26/2026